Today: 10 March 2026
Browse Category

Earnings Reports 12 January 2026

Why Johnson & Johnson stock is up today: new Rybrevant data and earnings ahead

Why Johnson & Johnson stock is up today: new Rybrevant data and earnings ahead

Johnson & Johnson shares rose 2.3% to $209.03 after new data showed its drug Rybrevant, combined with chemotherapy, produced a 51% response rate in metastatic colorectal cancer. The results, from the OrigAMI-1 trial, included a 73% response rate in first-line patients. The company’s fourth-quarter earnings report is due Jan. 21. J&J recently struck a deal with the Trump administration to lower U.S. drug prices.
Procter & Gamble stock rises as defensive staples rally on Powell probe; PG earnings ahead

Procter & Gamble stock rises as defensive staples rally on Powell probe; PG earnings ahead

Procter & Gamble shares rose about 1% to $143.29 Monday afternoon, outpacing the S&P 500’s 0.2% gain as consumer-staples stocks advanced. The move came amid renewed market volatility after news broke of a criminal probe into Fed Chair Jerome Powell. Investors are watching U.S. inflation data and P&G’s Jan. 22 earnings report for further direction.
Pure Storage stock jumps nearly 8% as investor focus turns to insider filing, CPI and a Needham webcast

Pure Storage stock jumps nearly 8% as investor focus turns to insider filing, CPI and a Needham webcast

Pure Storage shares rose 7.9% to $72.29 on Monday, outpacing the broader market. A Friday filing showed founder John Colgrove transferred 200,000 shares as gifts between family trusts. Investors are watching Tuesday’s U.S. CPI report and Pure’s presentation at the Needham Growth Conference on Thursday. Peer stocks, including NetApp and Western Digital, also advanced.
Gold Fields stock jumps as gold breaks $4,600; CPI and earnings in focus

Gold Fields stock jumps as gold breaks $4,600; CPI and earnings in focus

Gold Fields shares surged 6.7% to $48.73 in New York Monday after gold prices hit a record high, prompting gains across gold miners. The rally followed safe-haven buying and a weaker dollar ahead of Tuesday’s U.S. inflation report. Gold Fields earlier touched $49.58, with Newmont, AngloGold Ashanti, and Wheaton Precious Metals also advancing. Investors await CPI data for clues on rates and sector momentum.
Twist Bioscience stock jumps on early revenue beat as TWST investors eye JPM talk and Feb. 2 results

Twist Bioscience stock jumps on early revenue beat as TWST investors eye JPM talk and Feb. 2 results

Twist Bioscience shares rose nearly 8% Monday after preliminary fiscal Q1 revenue reached about $103.7 million, beating company forecasts. DNA Synthesis and Protein Solutions sales climbed 27% to $51.1 million, while NGS Applications revenue hit $52.6 million. CEO Emily Leproust cited strong demand in both segments. Full audited results are due Feb. 2.
ServiceNow stock steadies after Goldman’s fresh “Buy” call as earnings near

ServiceNow stock steadies after Goldman’s fresh “Buy” call as earnings near

Goldman Sachs initiated coverage of ServiceNow with a Buy rating and a $205 price target Monday, sending shares up 0.2% to around $142 in afternoon trading. The move follows a 3% drop last week. Investors are focused on ServiceNow’s Jan. 28 earnings report for signals on 2026 growth and demand. Stifel recently cut its price target to $200, citing concerns over federal contract trends.
Spotify stock slips as Wall Street digests Fed pressure — CPI and earnings ahead for SPOT

Spotify stock slips as Wall Street digests Fed pressure — CPI and earnings ahead for SPOT

Spotify shares fell 1.2% to $532.97 by midday Monday, underperforming a steady U.S. market as investors eyed political pressure on the Federal Reserve and looming inflation data. The S&P 500-tracking SPY ETF rose 0.1%. Attention is turning to Spotify’s quarterly report on February 10 for updates on subscription pricing and ad demand.
Lumentum stock drops 5% in late morning trade as AI optics bets cool ahead of earnings

Lumentum stock drops 5% in late morning trade as AI optics bets cool ahead of earnings

Lumentum Holdings shares fell 5.4% to $332.28 Monday, underperforming a flat U.S. market. The drop followed news that chief accounting officer Matthew Sepe will step down in early February, with Eric Chang set to replace him. Investors are awaiting Lumentum’s Feb. 3 earnings report and conference call. The stock touched an intraday low of $323.24.
Robinhood (HOOD) stock jumps as bitcoin climbs; traders eye earnings and fresh scrutiny on event contracts

Robinhood (HOOD) stock jumps as bitcoin climbs; traders eye earnings and fresh scrutiny on event contracts

Robinhood shares rose 3.6% to $119.38 by late morning Monday, rebounding after an early drop. Bitcoin gained 1.2% to $92,046, while most crypto-linked stocks were steady. Investors are watching Robinhood’s Feb. 10 earnings and regulatory moves against sports event contracts, a sector the company is expanding into. Tennessee and Connecticut regulators have targeted several firms, including Robinhood, over unlicensed sports wagering.
AST SpaceMobile stock slips in volatile trade as ASTS investors eye next launch steps and earnings

AST SpaceMobile stock slips in volatile trade as ASTS investors eye next launch steps and earnings

AST SpaceMobile shares fell 1.9% to $95.81 Monday after volatile trading, following the December launch of its BlueBird 6 satellite. Investors await the company’s quarterly results in March and updates on satellite deployment. AST aims to launch 45 to 60 satellites by the end of 2026. Other satellite connectivity stocks, including Globalstar and Iridium, rose modestly.
Moderna stock slides as $1.9 billion sales view fails to calm investors (MRNA)

Moderna stock slides as $1.9 billion sales view fails to calm investors (MRNA)

Moderna shares fell 4% to $32.92 Monday after the company raised its 2025 revenue forecast to $1.9 billion and projected operating expenses of up to $5.2 billion. CFO Jamey Mock said U.S. retail vaccination rates dropped 26% in 2025. The company expects about $8.1 billion in year-end cash, including $600 million from a new loan. Investors remain cautious as pandemic demand fades and late-stage vaccine trial results approach.
Abercrombie & Fitch stock dives after holiday update trims sales outlook — what investors watch next

Abercrombie & Fitch stock dives after holiday update trims sales outlook — what investors watch next

Abercrombie & Fitch shares fell about 20% Monday after the retailer cut its holiday-quarter outlook and trimmed its full-year sales growth forecast to at least 6%. The company cited higher planned spending and $90 million in tariff costs in its revised guidance. Fourth-quarter net sales are now projected to rise around 5%, below analyst estimates. Capital expenditure targets increased to $245 million.
Tesla stock pops at the open as robotaxi “prove-it year” talk meets earnings countdown

Tesla stock pops at the open as robotaxi “prove-it year” talk meets earnings countdown

Tesla shares rose 2.1% to $445.01 in early New York trading Monday. The company delivered 418,227 vehicles in the fourth quarter, about 1% below analyst estimates, but set a record for energy storage deployments. Rivian, GM, and Ford all traded lower. Tesla is set to report earnings Jan. 28, with investors focused on robotaxi updates and profitability.
Citigroup stock slides as Trump’s 10% credit-card rate cap plan rattles lenders ahead of earnings

Citigroup stock slides as Trump’s 10% credit-card rate cap plan rattles lenders ahead of earnings

Citigroup shares fell 3.5% to $117.03 after President Trump proposed a one-year 10% cap on credit card interest rates, with no details on enforcement. Analysts said such a cap would likely require congressional action. The Supreme Court declined to hear Citigroup’s appeal in a fraud lawsuit tied to its Banamex unit, allowing the case to proceed. Capital One and American Express also dropped sharply.
1 119 120 121 122 123 227
Go toTop